Sep 1, 2026 10:17AM

Sep 1, 2026 07:33AM

Aug 27, 2026 04:01PM

Aug 13, 2026 05:39AM

Jul 1, 2026 06:06AM

Jun 11, 2026 08:12AM

Apr 15, 2026 08:01AM Kazia Therapeutics names Dr. Sudha Rao as chief scientific officer

Apr 15, 2026 02:24AM

Apr 13, 2026 05:07PM

Mar 18, 2026 06:11AM

Jan 30, 2026 08:00AM

Jan 28, 2026 06:48AM

Dec 22, 2025 08:02AM

Dec 12, 2025 06:43AM Kazia Therapeutics (KZIA) PT Raised to $18 at H.C. Wainwright

Dec 10, 2025 08:03AM

Nov 18, 2025 04:15PM

Oct 28, 2025 06:43AM

Oct 27, 2025 07:16AM

Oct 7, 2025 08:33AM

Oct 2, 2025 08:31AM

Sep 11, 2025 08:01AM Kazia reports paxalisib disrupted cancer cell clusters in lab study

Jul 10, 2025 06:42AM

Jul 9, 2025 08:00AM

Jun 11, 2025 08:00AM

Mar 31, 2025 07:31AM

Feb 20, 2025 08:46AM

Jan 30, 2025 07:31AM

Jan 10, 2025 10:01AM Kazia Therapeutics (KZIA) Announces $2.0 Million Registered Direct Offering

Dec 31, 2024 08:00AM

Nov 4, 2024 07:31AM

Oct 2, 2024 08:47AM

Sep 12, 2024 07:30AM

Jul 12, 2024 08:18AM

Jul 10, 2024 07:30AM

Jul 10, 2024 07:30AM Kazia Therapeutics (KZIA) Reports Phase 2/3 Trial Results for Paxalisib in Glioblastoma

Jun 25, 2024 06:06AM

443,976 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All